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 Project Background: 
Bone is a dynamic and highly vascular tissue, but measuring markers 
of microvascular haemodynamics within bone is currently difficult.  
There are logistical and technical limitations with existing tests 
based around MRI and radioisotope scans, in part due to bone’s high 
density and mineral content. This complicates studying bone 
diseases where microvascular dysfunction plays a pathogenic role.   
Near infrared spectroscopy (NIRS) has the potential to measure 
bone haemodynamic markers in real time and is safe and 
inexpensive. It also provides information on oxygen levels within 
bone, previously only possible with bone biopsy. NIRS utilises similar 
technology to a pulse oximeter, transmitting and receiving 
designated optical frequencies using non-invasive probes at a 
specific anatomical sight and measuring tissue depths of up to 4cms 
(Figure 1). NIRS takes advantage of the differences in attenuation 
caused by oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb).  
This provides haemodynamic markers such as: 
 Total oxygenation index (TOI): The ratio of O2Hb to total 
haemoglobin (cHb); 
 Normalised total haemoglobin index (nTHI): Real time 
percentage change in cHb concentration from an initial 
baseline measurement; and, 
 Real time absolute concentration changes of HHb, 
O2Hb and cHb [1]. 
The use of near infrared spectroscopy (NIRS) as a diagnostic tool to measure microvascular haemodynamics in bone tissue.  
Primary Aim and Objectives: 
To investigate the potential of NIRS as a diagnostic tool in 
the measurement of microvascular haemodynamics in 
bone tissue, including whether NIRS: 
1) Can exclusively measure bone tissue, based on the 
known physiological differences between bone and 
muscle.   
2) Can provide reproducible measurements across 
different anatomical sites, participants and operators.   
 
Methods: 
Testing was carried out on healthy volunteers, recruited 
using convenience sampling, with institutional ethical 
approval. Participants were positioned supine with 
baseline TOI measurements taken at four different 
superficial bony anatomical locations (proximal tibia (TP), 
tibial diaphysis (TD), medial malleolus (MM) and patella) 
and one muscle location, as shown in Figure 2.  
Femoral artery occlusions were undertaken whilst 
simultaneously taking NIRS measurements at a bony site 
(TD or TP) and the muscle site before, during and after 
occluding blood flow at the distal thigh (Figure 3 shows 
set up).   
Arterial occlusion integrity was confirmed by a decrease 
in TOI and simultaneous matched changes in HHb and 
O2Hb during and after occlusion, with a nTHI change of 
less than +/- 15% during occlusion suggesting blood 
volume remained constant (Figure 4).   
Results: 
Baseline TOI measurements on 15 participants demonstrated statistically 
significant differences between baseline TOI at the four bone sites and the muscle 
site. The variability of results at the preferred TD and TP bone sites was 
comparable to muscle readings (an established site for NIRS measurements). 
 
 
 
 
 
 
 
 
 
Conclusions: 
Despite the statistical significance of the measured differences between bone and muscle, the physiological importance of these 
differences remains essentially unknown due to a paucity of research in this field. However, the results of this feasibility work are 
encouraging and justify further research into the use of NIRS as a diagnostic tool for bone pathologies including microvascular 
pathogenesis, such as osteoporosis, non-union, osteoarthritis, Pagets, and/or blood bourne cancers. If successful, further studies 
investigating the use of NIRS in more diverse populations would be justified. This could lead to inexpensive, quick and tolerable 
methods of measuring microvascular supply in bone. 
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Figure 1: The Hamamatsu NIRO 
NX-200 (a) demonstrates the 
NIR emitting sensor probe (left) 
and the detector probe (right); 
(b) shows the typical real time 
display data including TOI, nTHI, 
O2Hb, HHb and cHb changes. 
Figure 2: Schematic probe positioning at four 
bony sites and one muscle site. 
Figure 3:  Arterial Occlusion set up: A BP cuff is 
around the distal femur.  NIRS probes are 
secured with bandages.   
Figure 4:  O2Hb and HHb experience equal 
and opposite changes during occlusion and at 
occlusion release.  
Occlusion 
Starts 
Occlusion 
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Figure 6:  Summary of baseline TOI results (standard deviation is in parenthesis; n=15)  
Figure 5: Box plot of mean baseline TOI values (n=15) 
  TD TP MM PATELLA MUSCLE 
Mean TOI (%) 80.55 (4.60) 83.00 (4.13) 81.18 (6.14) 82.20 (8.37) 70.05 (4.82) 
Coefficient of 
Variation (%) 
5.71 4.98 7.56 10.18 6.88 
Wilcoxon 
signed-rank 
test vs muscle 
p<0.001 p<0.001 p<0.01 p<0.01  n/a 
 
 
DATA FROM TP ARTERIAL OCCLUSIONS TP Bone SD Muscle SD p-value 
TOI Baseline (%) 81.65 4.14 70.96 5.00 0.0029 
TOI desat (%/min) -1.62 0.54 -3.64 1.77 0.0121 
HHb desat rate (µM.cm/min) 23.28 7.25 52.79 23.87 0.0047 
TOI resat (%/min) 16.24 11.86 75.19 31.40 0.0022 
HHb resat rate (µM.cm/min) -146.26 91.59 -812.00 370.12 0.0022 
Hyperaemic Response (% TOI) 0.69 1.44 5.80 3.20 0.0022 
DATA FROM TD ARTERIAL OCCLUSIONS TD Bone SD Muscle SD p-value 
TOI Baseline (%) 80.08 5.05 70.83 4.58 0.0008 
TOI desat (%/min) -1.86 0.55 -3.94 1.96 0.0045 
HHb desat rate (µM.cm/min) 28.02 6.27 54.32 24.70 0.0045 
TOI resat (%/min) 16.85 7.51 67.89 27.03 0.0008 
HHb resat rate (µM.cm/min) -153.61 56.53 -711.95 301.96 0.0007 
Hyperaemic Response (% TOI) 1.17 1.34 5.93 2.53 0.0007 
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Figure 7: Graphs show an individual example of observed differences in bone (blue) and muscle (orange) physiology.  
Figure 8: Descriptive results of TD, TP and muscle physiological data. Wilcoxon 
signed–rank tests demonstrate statistically significant differences between bone 
and muscle. 
32 arterial occlusions were attempted on 15 participants 
(alternating between TD and TP) of which 27 sets of 
successfully paired bone and muscle data (12 TP and 15 TD) 
were recorded.  There was a significant statistical difference 
demonstrated between bone sites and the simultaneous 
muscle tissue data taken for a number of different parameters 
including: 
- Baseline pre occlusion TOI means;  
- Post occlusion gradients of TOI and HHb desaturation; 
- Occlusion release gradients of TOI and HHb measured during 
the first 20 seconds post cuff release; and,  
- Hyperaemic response upon occlusion release.   
Variability is higher with occlusion data but is again 
comparable between bone and muscle readings. Further 
investigations showed no obvious systematic confounding in 
results caused by age, gender or leg circumference. 
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